Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval variations module. The module for post-approval variations covers regulatory changes across multiple countries, offering meticulously curated requirements to streamline tracking. With this update, pharmaceutical, biotech, and generics companies can effortlessly navigate the regulatory process and prioritize essential actions.
Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval
Related Posts
David (Microsoft) Vs. Goliath (Google) Battle For AI Dominance: How Analysts See Alphabet Faring
Technology giant Alphabet Inc (NASDAQ: GOOG)(NASDAQ: GOOGL) reported first quar
Why Okta Stock Is Rising After Hours
Okta, Inc. (NASDAQ: OKTA) shares popped after-hours Wednesday after the company reported second-quarter earnings and issued guidance.
Grove Collaborative Hldgs Q4 EPS $(0.08) Beats $(0.09) Estimate, Sales $74.00M Beat $69.00M Estimate
Grove Collaborative Hldgs (NYSE:GROV) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 11.11 percent. The company reported quarterly sales of $74.00 million which